Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003209
Filing Date
2024-02-09
Accepted
2024-02-09 17:51:56
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 form4-02092024_100244.html 4  
1 form4-02092024_100244.xml 4 4441
  Complete submission text file 0001415889-24-003209.txt   5983
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Scopa James Paul (Reporting) CIK: 0001356950 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 24616529

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)